Delea, T E <br/><br/>
Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jan 2007 
 - 197-198 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdl171  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aromatase Inhibitors--economics<br/>Breast Neoplasms--drug therapy<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Female<br/>Humans<br/>Postmenopause